WuXi Biologics (Cayman) Inc.

Direct answer

WuXi Biologics (Cayman) Inc. is publicly traded on HKSE under the ticker 2269.HK.

Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its...

Can you invest in WuXi Biologics (Cayman) Inc.?

Yes. WuXi Biologics (Cayman) Inc. trades publicly on HKSE as 2269.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for WuXi Biologics (Cayman) Inc.

Detailed equity research is provided by MarketSnap.